Elon Musk Loses Court Battle Against Sam Altman and OpenAI After ThreeWeek Trial Linde plc LIN Crushes Q1 2026 Estimates EPS 433 Tops Views abrdn FCO Stock Down 077 Support Test at 244 20260515 Equator Beverage Co Releases Latest Quarterly Earnings Report US Jobless Claims Remain Low Signaling Continued Labor Market Tightness Apples WWDC in Focus as AI Strategy Faces Key Test The Pitfalls of Chasing Returns Why Consistency Matters More Than Past Performance Julian Alvarez Contract Standoff FC Barcelona Alerted as Atletico Madrid Star Refuses Extension Could SpaceXs MegaIPO Signal a Market Peak Analysts Weigh In Geopolitical Tensions Rise as Putin Vows Retaliation After Alleged Ukrainian Strike on Military Target LPL Q1 2026 Earnings Staggering EPS Miss Drives Sharp Stock Decline News Corporation NWS Q1 2026 Earnings EPS Beats Estimates by 1206 Despite Stock Decline Keysight Technologies Q1 2026 Earnings Strong EPS Beat of 212 Amid Revenue Uncertainty CCB Q1 2026 Earnings EPS Falls Short as Profitability Pressures Mount WORX Q3 2025 Earnings EPS Loss of 015 Amid Significant Stock Surge BGC Q1 2026 Earnings Slight EPS Miss Triggers Modest SellOff Cohen Steers REIT and Preferred Income Fund RNP Stabilizes Near 2080 as Market Digests Modest Decline Netcapital Inc NCPL Edges Lower Testing Support Near Key Inflection Point Amprius Technologies AMPX Surges 1182 Momentum Builds Above Key Support Weibo Corporation WB Edges Higher Consolidating Between Key Support and Resistance OKYO Pharma Shares Edge Higher as Biotech Momentum Builds Inhibikase Therapeutics IKT Recovers 35 as Buyers Defend Key Support Level LightWave Acquisition Corp LWAC Holds Steady at 1020 Amid Low Volume Ares Capital Corporation ARCC Holds Steady Near Support After a Modest Uptick Fluence Energy FLNC Edges Higher Consolidation or Building Momentum Ryder System R Slips Slightly Consolidation Near Resistance Levels Ubers Takeover Bid for Delivery Hero Reportedly Rejected Day One Biopharmaceuticals Q4 2025 Earnings EPS Miss Amid Continued RD Investment SELLAS Life Sciences Group SLS Surges 629 as Biotech Momentum Builds